BioCentury· BioCentury·· 4 小时前AI 评分58
BioCentury：中国前三季度逾四成交易涉及首创潜力项目
China dealmaking is growing its first-in-class footprint. More than 40% of China’s deals through 3Q were for programs with first-in-class...
AI 导读
BioCentury 称，截至第三季度，中国交易中超过 40% 涉及具有首创（first-in-class）潜力的项目，为至少四年来最高占比，显示中国交易的首创项目比重在上升。
阅读原文
来源：BioCentury · x.com